Sarah P Cate, MD Email Sarah Cate
-
- Position
- ASSISTANT PROFESSOR | Surgery
-
- Specialties
- Surgery
- Breast Cancer - Surgery
-
- Languages
- English
- Spanish
-
- Hospital Affiliations
- New York Eye and Ear Infirmary of Mount Sinai
- The Mount Sinai Hospital
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
-
- Phone
- The Blavatnik Family – Chelsea Medical Center 212-367-0133 212-367-0133
-
The Blavatnik Family – Chelsea Medical Center
325 West 15th Street
(between 8th and 9th Avenues)
New York, NY 10011
Phone: 212-367-0133212-367-0133
Dr. Sarah Cate is a fellowship-trained breast surgeon and a graduate of the Mount Sinai Beth Israel, Mount Sinai St. Luke’s and Mount Sinai West breast surgery fellowship. She is the lead physician for our Special Surveillance Breast Program at Mount Sinai Beth Israel, which is a member of the Mount Sinai Health System.
Dr. Cate focuses on increased-risk patients, as well as breast cancer and benign breast disease. She specializes in BRCA positive patients, as well as other patients with genetic mutations, and also specializes in prophylactic mastectomies, which are nipple sparing, with direct to implant reconstruction.
Dr. Cate is involved in several research projects and has presented her research at the national level on topics such as vitamin D and breast cancer, triple negative breast cancer, DCIS Oncotype, and tumor markers in early stage breast cancer.
Watch as Dr. Cate discusses breast reconstruction surgery on FacebookLive in honor of Breast Reconstruction Surgery Awareness Day.
Certification
American Board of Surgery
Clinical Focus
Research Topics
MRI, Metastasis
Education
MD, UMDNJ Robert Wood Johnson Medical School
Residency, Surgery (General)
Westchester Medical Center
Fellowship, Breast Sugery
Beth Israel Medical Center
Languages
English, Spanish
New topic
Dr. Cate is the principal investigator for a clinical trial investigating the use of cryoablation in early stage breast cancer. She also is investigating the use of mammography in women aged 75 and older.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Cate did not report having any of the following types of financial relationships with industry during 2018 and/or 2019: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.